| Descriptor English: | Ivabradine | ||||||
| Descriptor Spanish: |
Ivabradina
| ||||||
| Descriptor Portuguese: | Ivabradina | ||||||
| Descriptor French: | Ivabradine | ||||||
| Entry term(s): |
7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one Corlanor S 16257 S 16257 2 S 16257-2 S 162572 S 16260 2 S 16260-2 S 162602 S-16257 S-16257-2 S-16260-2 S16257 S162572 S162602 |
||||||
| Tree number(s): |
D03.633.100.079.801 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077550 | ||||||
| Scope note: | A benzazepine derivative and selective HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS inhibitor that lowers the heart rate. It is used in the treatment of CHRONIC STABLE ANGINA in patients unable to take BETA-ADRENERGIC BLOCKERS, and in the treatment of HEART FAILURE. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Cardiovascular Agents |
||||||
| Registry Number: | 3H48L0LPZQ | ||||||
| CAS Type 1 Name: | 2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- | ||||||
| Public MeSH Note: | 2019; IVABRADINE was indexed under BENZAZEPINES 1994-2018 |
||||||
| History Note: | 2019 (1994) |
||||||
| DeCS ID: | 57675 | ||||||
| Unique ID: | D000077550 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2019/01/01 | ||||||
| Date of Entry: | 2018/07/09 | ||||||
| Revision Date: | 2018/06/20 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Ivabradine
- Preferred
7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one
- Narrower
S 16257
- Narrower
S 16257-2
- Narrower
Corlanor
- Narrower
| Concept UI |
M0234009 |
| Scope note | A benzazepine derivative and selective HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS inhibitor that lowers the heart rate. It is used in the treatment of CHRONIC STABLE ANGINA in patients unable to take BETA-ADRENERGIC BLOCKERS, and in the treatment of HEART FAILURE. |
| Preferred term | Ivabradine |
| Concept UI |
M000640894 |
| Preferred term | 7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one |
| Concept UI |
M0234003 |
| Preferred term | S 16257 |
| Entry term(s) |
S-16257 S16257 |
| Concept UI |
M0234004 |
| Preferred term | S 16257-2 |
| Entry term(s) |
S 16257 2 S 162572 S 16260 2 S 16260-2 S 162602 S-16257-2 S-16260-2 S162572 S162602 |
| Concept UI |
M000605160 |
| Preferred term | Corlanor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey